Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?

Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease with dismal prognosis. Choosing the right treatment for each patient remains one of the major challenges. A new approach being explored is the use of ex vivo models for personalized medicine. Two-dimensional cult...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Diana, Lopes, Raquel, Pestana, Carolina, Queirós, Ana C., João, Cristina, Carneiro, Emilie Arnault
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657251/
https://www.ncbi.nlm.nih.gov/pubmed/36361677
http://dx.doi.org/10.3390/ijms232112888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657251/
https://www.ncbi.nlm.nih.gov/pubmed/36361677
http://dx.doi.org/10.3390/ijms232112888

Ejemplares similares